ANTI-CXCR2 ANTIBODIES AND USES THEREOF
Provided are anti-CXCR2 antibodies and antigen-binding fragments thereof. The antibodies or fragments thereof specifically bind to N-terminal, extracellular domain of the CXCR2 protein. In various example, the antibodies or fragments thereof include a VH CDR1 of SEQ ID NO: 1, a VH CDR2 of SEQ ID NO:...
Saved in:
Main Authors | , |
---|---|
Format | Patent |
Language | English |
Published |
20.10.2022
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Provided are anti-CXCR2 antibodies and antigen-binding fragments thereof. The antibodies or fragments thereof specifically bind to N-terminal, extracellular domain of the CXCR2 protein. In various example, the antibodies or fragments thereof include a VH CDR1 of SEQ ID NO: 1, a VH CDR2 of SEQ ID NO: 2, a VH CDR3 of SEQ ID NO: 3, or any one of SQ ID NO: 7-14, a VL CDR1 of SEQ ID NO: 4, a VL CDR2 of SEQ ID NO: 5, and a VL CDR3 of SEQ ID NO: 6, or variants of each thereof. Methods of using the antibodies or fragments thereof for treating and diagnosing diseases such as cancer and inflammatory diseases are also provided. |
---|---|
AbstractList | Provided are anti-CXCR2 antibodies and antigen-binding fragments thereof. The antibodies or fragments thereof specifically bind to N-terminal, extracellular domain of the CXCR2 protein. In various example, the antibodies or fragments thereof include a VH CDR1 of SEQ ID NO: 1, a VH CDR2 of SEQ ID NO: 2, a VH CDR3 of SEQ ID NO: 3, or any one of SQ ID NO: 7-14, a VL CDR1 of SEQ ID NO: 4, a VL CDR2 of SEQ ID NO: 5, and a VL CDR3 of SEQ ID NO: 6, or variants of each thereof. Methods of using the antibodies or fragments thereof for treating and diagnosing diseases such as cancer and inflammatory diseases are also provided. |
Author | Yang, Guang Shi, Xiaojie |
Author_xml | – fullname: Shi, Xiaojie – fullname: Yang, Guang |
BookMark | eNrjYmDJy89L5WRQc_QL8dR1jnAOMlIAMZ38XTxdg4FMF4XQYCAjxMM1yNXfjYeBNS0xpziVF0pzMyi7uYY4e-imFuTHpxYXJCan5qWWxIcGGxkYGRkbG1kYmzoaGhOnCgAhSiX4 |
ContentType | Patent |
DBID | EVB |
DatabaseName | esp@cenet |
DatabaseTitleList | |
Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Chemistry Sciences |
ExternalDocumentID | US2022332835A1 |
GroupedDBID | EVB |
ID | FETCH-epo_espacenet_US2022332835A13 |
IEDL.DBID | EVB |
IngestDate | Fri Jul 19 12:51:33 EDT 2024 |
IsOpenAccess | true |
IsPeerReviewed | false |
IsScholarly | false |
Language | English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-epo_espacenet_US2022332835A13 |
Notes | Application Number: US202017640309 |
OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20221020&DB=EPODOC&CC=US&NR=2022332835A1 |
ParticipantIDs | epo_espacenet_US2022332835A1 |
PublicationCentury | 2000 |
PublicationDate | 20221020 |
PublicationDateYYYYMMDD | 2022-10-20 |
PublicationDate_xml | – month: 10 year: 2022 text: 20221020 day: 20 |
PublicationDecade | 2020 |
PublicationYear | 2022 |
RelatedCompanies | ShanghaiTech University |
RelatedCompanies_xml | – name: ShanghaiTech University |
Score | 3.4261026 |
Snippet | Provided are anti-CXCR2 antibodies and antigen-binding fragments thereof. The antibodies or fragments thereof specifically bind to N-terminal, extracellular... |
SourceID | epo |
SourceType | Open Access Repository |
SubjectTerms | CHEMISTRY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PEPTIDES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
Title | ANTI-CXCR2 ANTIBODIES AND USES THEREOF |
URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20221020&DB=EPODOC&locale=&CC=US&NR=2022332835A1 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dS8MwED_GFPVNp-LHlILSt2JtujR9KLKmLVVYO7pW-jbatYWBzOEq_vteQqd72tslgcsH3MfvktwBPFJa2RUbiRqAJtHMglQaaxjV7KIwGKOlWclgziSiYWa-5aO8Bx_bvzAyT-iPTI6IErVAeW-lvl7_B7E8-bZy81QusevzJUgdT-3QsSEAjK56ruNPYy_mKudONlOjRI4RIpKLjRErHaAjbQl58N9d8S9lvWtUglM4nCK_VXsGvXo1gGO-rb02gKNJd-WNZCd9m3NQx1H6qvGcJ4YiSDcWzhySnpKhWlTS0E_8OLiAh8BPeajhhPO__c2z2e7qyCX0EfnXV6CYjV5Ylv3MCoRxrNZZvaDCwtakMK2SNtcw3MfpZv_wLZyIplDEhj6Efvv1Xd-hhW3Le3kwv3S4eRM |
link.rule.ids | 230,309,783,888,25576,76876 |
linkProvider | European Patent Office |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LT4NAEJ401VhvWjVWq5JouBER6LIciCkLhGoLTQuGWwMFEhNTG4vx7zu7odpTb5OdZPaRzOPb3ZkBeCCksAo64D0ADV0xMr1QaEWJYmWZRinJjUJc5kxCEiTGSzpIW_CxzYURdUJ_RHFE1Kgl6nst7PX6_xLLFX8rN4_5Ow59Pvux7coNOtY4gFFl17G9aeRGTGbMTuZyOBM8XefFxYaIlQ4wyDa5PnhvDs9LWe86Ff8EDqcob1WfQqtcdaHDtr3XunA0aZ68kWy0b3MG8jCMRwpL2UyTOOlEPJhD0pUSNItSHHgzL_LP4d73YhYoOOHib3-LZL67Ov0C2oj8y0uQjErNTNN6ohnCOFqqtFwS7mFLPTPMnFQ96O-TdLWffQedIJ6MF-NR-HoNx5zFjbKm9qFdf32XN-ht6_xWHNIvTbl8Bg |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=ANTI-CXCR2+ANTIBODIES+AND+USES+THEREOF&rft.inventor=Shi%2C+Xiaojie&rft.inventor=Yang%2C+Guang&rft.date=2022-10-20&rft.externalDBID=A1&rft.externalDocID=US2022332835A1 |